Overview

Mavoglurant in Alcohol Drinking

Status:
Recruiting
Trial end date:
2022-07-30
Target enrollment:
Participant gender:
Summary
The purpose of this alcohol-interaction pilot study is to provide information on the effect of mavoglurant on the pharmacokinetics of alcohol and on alcohol responses, including stimulation, sedation, intoxication, body sway and physiological responses. The investigators propose to test the effects of 200 mg mavoglurant versus placebo on alcohol related responses. This is a between subjects double blind randomized design in which the investigators plan to run 40 subjects to obtain 28 completers.
Phase:
Phase 1
Details
Lead Sponsor:
Yale University